Remdesivir alleviates skin fibrosis by suppressing TGF-β1 signaling pathway
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0305927 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jianwei Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, College of Life Sciences, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Signal Transduction, Transforming Growth Factor beta1, Fibrosis, Alanine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin, China, 111 Project.
Abstract (Originalsprache)
Fibrotic skin diseases, such as keloids, are pathological results of aberrant tissue healing and are characterized by overgrowth of dermal fibroblasts. Remdesivir (RD), an antiviral drug, has been reported to have pharmacological activities in a wide range of fibrotic diseases. However, whether RD function on skin fibrosis remains unclear. Therefore, in our study, we explored the potential effect and mechanisms of RD on skin fibrosis both in vivo and in vitro . As expected, the results demonstrated that RD alleviated BLM‐induced skin fibrosis and attenuates the gross weight of keloid tissues in vivo . Further studies suggested that RD suppressed fibroblast activation and autophagy both in vivo and in vitro . In addition, mechanistic research showed that RD attenuated fibroblasts activation by the TGF‐β1/Smad signaling pathway and inhibited fibroblasts autophagy by the PI3K/Akt/mTOR signaling pathway. In summary, our results demonstrate therapeutic potential of RD for skin fibrosis in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, College of Life Sciences, Nankai University, Tianjin, China.
- Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
- Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
- Department of Dermatology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
ORCID-Profile: Honggang Zhou
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin, China
- 111 Project
Zitieren
APA
Zhang, J., Zhang, X., Guo, X., Li, W., Zhang, T., Chai, D., Liu, Y., Chen, L., Ai, X., Zhou, T., Wei, W., Gu, X., Li, X., & Zhou, H. (2024). Remdesivir alleviates skin fibrosis by suppressing TGF-β1 signaling pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0305927
Vancouver
Zhang J, Zhang X, Guo X, Li W, Zhang T, Chai D, et al. Remdesivir alleviates skin fibrosis by suppressing TGF-β1 signaling pathway. PLOS ONE. 2024. doi:10.1371/journal.pone.0305927
BibTeX
@article{Zhang2024,
author = {Zhang, Jianwei and Zhang, Xiujun and Guo, Xiaowei and Li, Wenqi and Zhang, Tiantian and Chai, Dan and Liu, Yuming and Chen, Li and Ai, Xiaoyu and Zhou, Tianyuan and Wei, Wenguo and Gu, Xiaoting and Li, Xiaohe and Zhou, Honggang},
title = {Remdesivir alleviates skin fibrosis by suppressing TGF-β1 signaling pathway},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0305927}
}
EUVIMED